Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A).
Heffeter P, Pongratz M, Steiner E, Chiba P, Jakupec MA, Elbling L, Marian B, Körner W, Sevelda F, Micksche M, Keppler BK, Berger W. Heffeter P, et al. Among authors: berger w. J Pharmacol Exp Ther. 2005 Jan;312(1):281-9. doi: 10.1124/jpet.104.073395. Epub 2004 Aug 26. J Pharmacol Exp Ther. 2005. PMID: 15331656
Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24).
Heffeter P, Jakupec MA, Körner W, Wild S, von Keyserlingk NG, Elbling L, Zorbas H, Korynevska A, Knasmüller S, Sutterlüty H, Micksche M, Keppler BK, Berger W. Heffeter P, et al. Among authors: berger w. Biochem Pharmacol. 2006 Feb 14;71(4):426-40. doi: 10.1016/j.bcp.2005.11.009. Epub 2005 Dec 15. Biochem Pharmacol. 2006. PMID: 16343446
Anticancer effects of zoledronic acid against human osteosarcoma cells.
Kubista B, Trieb K, Sevelda F, Toma C, Arrich F, Heffeter P, Elbling L, Sutterlüty H, Scotlandi K, Kotz R, Micksche M, Berger W. Kubista B, et al. Among authors: berger w. J Orthop Res. 2006 Jun;24(6):1145-52. doi: 10.1002/jor.20129. J Orthop Res. 2006. PMID: 16602111 Free article.
Resistance against novel anticancer metal compounds: differences and similarities.
Heffeter P, Jungwirth U, Jakupec M, Hartinger C, Galanski MS, Elbling L, Micksche M, Keppler B, Berger W. Heffeter P, et al. Among authors: berger w. Drug Resist Updat. 2008 Feb-Apr;11(1-2):1-16. doi: 10.1016/j.drup.2008.02.002. Epub 2008 Apr 3. Drug Resist Updat. 2008. PMID: 18394950 Review.
1,161 results